Topicals, generic [Regulatives / Guidelines]

posted by ioanam – Romania, 2013-04-01 09:51 (4463 d 00:26 ago) – Posting: # 10318
Views: 25,784

Thank you very much for your responses.

I consider that EMA must present a clear guideline for this type of products in order to have the same procedure in all EU countries because in some countries is still possible to obtain MA as a well established use product, while other authorities requires more and more trials. This is not ok.

We are all equal, but some are more equal than others (Sorry for this satirical quote adapted to this situation). :yes:

Wish you a beautiful week,
Ioana

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,676 registered users;
35 visitors (0 registered, 35 guests [including 10 identified bots]).
Forum time: 10:17 CEST (Europe/Vienna)

Complex, statistically improbable things are by their nature
more difficult to explain than
simple, statistically probable things.    Richard Dawkins

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5